sprite-preloader
Anzeige
Mehr »
Freitag, 22.02.2019 Börsentäglich über 12.000 News von 595 internationalen Medien

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Devisen

Kurs

%

Rohstoffe

Kurs

%

Passende Knock-Outs zu Ihrer Suchanfrage (Anzeige)
Erweiterte
Suche
lynx
Ad hoc-Mitteilungen

Aktuelle News zu Aktien im NASDAQ Biotech

  • 24 h
  • 7 Tage
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache:
LeserMedien
15:58Coherus BioSciences, Inc.: Coherus BioSciences Announces New Employment Inducement Grants-

► Artikel lesen
15:40The Daily Biotech Pulse: BioMarin Slips On Earnings, TherapeuticsMD Posts In-Line Results, Orchard To Present Immunodeficiency Drug Data2

► Artikel lesen
15:35BioMarin CEO JJ Bienaimé is planning for a blockbuster future in the gene therapy biz: to the tune of $10B to $15B a year1

► Artikel lesen
15:35Mylan launches generic sublingual film for opioid dependence-

► Artikel lesen
14:58Alder Bio files U.S. marketing application for migraine med eptinezumab1

► Artikel lesen
14:46Dermira launches study evaluating QBREXZA cloth; shares up 2% premarket-

► Artikel lesen
14:35Mylan launches generic suboxone sublingual film in U.S.1

► Artikel lesen
14:29BioMarin (BMRN) Q4 Earnings & Sales Miss, Shares Decline4

► Artikel lesen
14:22AbbVie And Voyager Therapeutics Collaborate To Develop Vectorized Antibodies7

► Artikel lesen
14:20Voyager Therapeutics stock soars after AbbVie collaboration potentially valued at over $1 billion4

► Artikel lesen
14:11Voyager Therapeutics, Inc. - 8-K, Current Report1

► Artikel lesen
14:07AbbVie (ABBV), Voyager Therapeutics (VYGR) Enter Pact to Develop Vectorized Antibodies to Treat Parkinson's Disease and Other Synucleinopathies4

► Artikel lesen
14:06Mylan (MYL) Launches Generic Suboxone Sublingual Film to Treat Opioid Dependence1

► Artikel lesen
14:06Alder BioPharma (ALDR) Reports Submission of Biologics License Application to FDA for Eptinezumab1

► Artikel lesen
14:06Dermira (DERM) Commences Proof-of-Concept Study to Evaluate QBREXZA (glycopyrronium) Cloth in Patients with Primary Palmar Hyperhidrosis-

► Artikel lesen
14:05MOMENTA PHARMACEUTICALS INC - 8-K, Current Report-

► Artikel lesen
13:46Insmed net loss widens in Q42

► Artikel lesen
13:46Nomura bearish on Xencor in premarket analyst action1

► Artikel lesen
13:36Myriad Genetics (MYGN) Reports Publication of Clinical Studies for Vectra Showing Better Prediction Results for Radiographic Progression in People with RA-

► Artikel lesen
13:36Insmed (INSM) Misses Q4 EPS by 10c, Revenues Beat; Offers FY19 Revenue Outlook Above Consensus-

► Artikel lesen
Seite:  Weiter >>